Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $23.39M | $22.28M | $15.52M | $34.01M |
| Net Income | $5.49M | $6.90M | $3.52M | $15.03M |
| EPS Diluted | $0.37 |
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
| $0.45 |
| $0.23 |
| $0.97 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
